Literature DB >> 21110212

Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis.

Björn Sundström1, Solveig Wållberg-Jonsson, Gunnar Johansson.   

Abstract

The aims of this study were to investigate, firstly, the relationship between diet and disease activity and, secondly, the presence of gastrointestinal symptoms and their relationship to diet among patients with ankylosing spondylitis (AS) using a cross-sectional design. One hundred sixty-five individuals diagnosed with AS were invited to complete a self-administered postal questionnaire regarding demographic data, diet, medication, and gastrointestinal symptoms in addition to two established disease assessment questionnaires, i.e., the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI). No significant correlation between diet and disease activity was found. Overall, 27% of the patients reported aggravating gastrointestinal problems when consuming certain foodstuff(s). The 30% of patients who reported suffering from gastrointestinal pain had significantly greater disease activity and poorer functional status according to their BASDAI and BASFI scores (p < 0.01 and p = 0.01, respectively). Patients who reported gastrointestinal pain had a significantly higher consumption of vegetables (p < 0.01) and lower consumption of milk and soured milk (p = 0.04). No significant correlation was found between the use of non-steroidal anti-inflammatory drugs (NSAID) and gastrointestinal symptoms. In multiple regression models, BASDAI and the consumption of vegetables were independent and statistically significant predictors of gastrointestinal pain. To conclude, in a group of Swedish AS patients, no correlation between diet and disease activity could be detected. There were, however, correlations between diet and gastrointestinal pain. Gastrointestinal problems were also found to be prevalent in AS, independent of NSAID usage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21110212     DOI: 10.1007/s10067-010-1625-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

1.  Self-reported food intolerance in chronic inflammatory bowel disease.

Authors:  M Ballegaard; A Bjergstrøm; S Brøndum; E Hylander; L Jensen; K Ladefoged
Journal:  Scand J Gastroenterol       Date:  1997-06       Impact factor: 2.423

2.  The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity.

Authors:  H Cronstedt; A Waldner; C H Stenström
Journal:  Scand J Rheumatol Suppl       Date:  1999

Review 3.  Ankylosing spondylitis and bowel disease.

Authors:  Martin Rudwaleit; Dominique Baeten
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-06       Impact factor: 4.098

4.  Validation and calibration of food-frequency questionnaire measurements in the Northern Sweden Health and Disease cohort.

Authors:  Ingegerd Johansson; Göran Hallmans; Asa Wikman; Carine Biessy; Elio Riboli; Rudolf Kaaks
Journal:  Public Health Nutr       Date:  2002-06       Impact factor: 4.022

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome.

Authors:  Derrick K Ong; Shaylyn B Mitchell; Jacqueline S Barrett; Sue J Shepherd; Peter M Irving; Jessica R Biesiekierski; Stuart Smith; Peter R Gibson; Jane G Muir
Journal:  J Gastroenterol Hepatol       Date:  2010-08       Impact factor: 4.029

7.  Ankylosing spondylitis and inflammatory bowel disease. I. Prevalence of inflammatory bowel disease in patients suffering from ankylosing spondylitis.

Authors:  S G Meuwissen; B J Dekker-Saeys; D Agenant; G N Tytgat
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

8.  The events registration and survey procedures in the Northern Sweden MONICA Project.

Authors:  Birgitta Stegmayr; Vivan Lundberg; Kjell Asplund
Journal:  Scand J Public Health Suppl       Date:  2003       Impact factor: 3.021

9.  Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.

Authors:  Juan Kong; Zhongyi Zhang; Mark W Musch; Gang Ning; Jun Sun; John Hart; Marc Bissonnette; Yan Chun Li
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-10-25       Impact factor: 4.052

10.  Association of macroscopic gut inflammation with disease activity, functional status and quality of life in ankylosing spondylitis.

Authors:  Gulen Hascelik; Bengi Oz; Nese Olmez; Asuman Memis; Gazi Yoruk; Belkis Unsal; Nese Ekinci
Journal:  Rheumatol Int       Date:  2008-11-22       Impact factor: 2.631

View more
  7 in total

Review 1.  Relationship between diet and ankylosing spondylitis: A systematic review.

Authors:  Tatiana V Macfarlane; Hadeel M Abbood; Ejaz Pathan; Katy Gordon; Juliane Hinz; Gary J Macfarlane
Journal:  Eur J Rheumatol       Date:  2017-10-25

2.  Fatigue in patients with spondyloarthritis associates with disease activity, quality of life and inflammatory bowel symptoms.

Authors:  Simon M Stebbings; Gareth J Treharne; Katey Jenks; John Highton
Journal:  Clin Rheumatol       Date:  2013-12-10       Impact factor: 2.980

3.  Modifiable cardiovascular risk factors in patients with ankylosing spondylitis.

Authors:  Björn Sundström; Gunnar Johansson; Ingegerd Johansson; Solveig Wållberg-Jonsson
Journal:  Clin Rheumatol       Date:  2013-10-19       Impact factor: 2.980

4.  Exercise habits and C-reactive protein may predict development of spinal immobility in patients with ankylosing spondylitis.

Authors:  Björn Sundström; Lotta Ljung; Solveig Wållberg-Jonsson
Journal:  Clin Rheumatol       Date:  2018-07-18       Impact factor: 2.980

5.  Effectiveness and Safety of Certolizumab Pegol in Axial Spondyloarthritis in a Real-World Setting in Greece: A Sub-Analysis of the Prospective Non-Interventional CIMAX Cohort Study.

Authors:  Gkikas Katsifis; Athina Theodoridou; Andreas Bounas; Panagiotis Georgiou; Petros Sfikakis; Kalliopi Fragiadaki; Theodoros Dimitroulas; Evangelia Mole; Lars Bauer; Thomas Kumke; Bengt Hoepken
Journal:  Mediterr J Rheumatol       Date:  2022-04-15

6.  Gastrointestinal Symptoms and Elevated Levels of Anti-Saccharomyces cerevisiae Antibodies Are Associated with Higher Disease Activity in Colombian Patients with Spondyloarthritis.

Authors:  C Romero-Sánchez; W Bautista-Molano; V Parra; J De Avila; J C Rueda; J M Bello-Gualtero; J Londoño; R Valle-Oñate
Journal:  Int J Rheumatol       Date:  2017-10-29

Review 7.  Nutrition in Spondyloarthritis and Related Immune-Mediated Disorders.

Authors:  Stefan Lucian Popa; Dinu Iuliu Dumitrascu; Vlad Dumitru Brata; Traian Adrian Duse; Maria Delia Florea; Abdulrahman Ismaiel; Laura Mirela Muntean; Simona Grad
Journal:  Nutrients       Date:  2022-03-17       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.